Distribution of prostate sentinel nodes: A SPECT-derived anatomic atlas

International Journal of Radiation Oncology Biology Physics

Volumn 79, Issue 5, 2011, Pages 1364-1372

  Ganswindt, Ute ^a   Schilling, David ^b   Müller, Arndt Christian ^b   Bares, Roland ^b   Bartenstein, Peter ^a   Belka, Claus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

High risk prostate cancer; Pelvic lymph node; Pelvic lymphatic drainage; Sentinel node; Single photon emission computed tomography

Indexed keywords

BIOCHEMICAL FAILURE; CLOSE PROXIMITY; DETECTION RATES; FUNCTIONAL IMAGES; INTENSITY-MODULATED RADIOTHERAPY; INTRA-OPERATIVE; LYMPH NODE; NANOCOLLOID; PELVIC LYMPH NODE; PELVIC LYMPH NODES; PELVIC LYMPHATIC DRAINAGE; PROGRESSION FREE SURVIVAL; PROSTATE CANCERS; RADIATION THERAPY ONCOLOGY GROUPS; SEMINAL VESICLE; SENTINEL LYMPH NODES; SENTINEL NODE; SINGLE PHOTON EMISSION; TARGET VOLUMES; THREE DIMENSIONAL VISUALIZATION;

BODY FLUIDS; DISEASES; IMAGE FUSION; NUCLEAR MEDICINE; PARTICLE BEAMS; PHOTONS; RADIOTHERAPY; TECHNETIUM; THREE DIMENSIONAL; THREE DIMENSIONAL COMPUTER GRAPHICS; TOMOGRAPHY; VISUALIZATION;

SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY;

NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; COMMON ILIAC LYMPH NODE; CONTROLLED STUDY; DEEP INGUINAL LYMPH NODE; EXTERNAL ILIAC LYMPH NODE; FUNCTIONAL ANATOMY; HIGH RISK PATIENT; HUMAN; IMAGE ANALYSIS; INFERIOR RECTAL LYMPH NODE; INGUINAL LYMPH NODE; INTERNAL ILIAC LYMPH NODE; INTERNAL PUDENDAL LYMPH NODE; LEFT PARAAORTIC LYMPH NODE; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PARAAORTIC LYMPH NODE; PERIPROSTATIC LYMPH NODE; PERIRECTAL LYMPH NODE; PERIVESICAL LYMPH NODE; PRIORITY JOURNAL; PROSTATE CANCER; RETROAORTIC LYMPH NODE; RIGHT PARAAORTIC LYMPH NODE; SACRAL LYMPH NODE; SEMINAL VESICLE LYMPH NODE; SENTINEL LYMPH NODE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUPERFICIAL INGUINAL LYMPH NODE; SUPERIOR RECTAL LYMPH NODE; THREE DIMENSIONAL IMAGING;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; LYMPH NODES; MALE; MEDICAL ILLUSTRATION; MIDDLE AGED; NEOPLASM STAGING; PELVIS; PROSTATIC NEOPLASMS; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79952697849     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.01.012     Document Type: Article

References (46)

1. Roach M 3rd, DeSilvio M, Lawton C, et al. Phase III trial comparing whole-pelvic versus prostate-only radiotherapy and neoadjuvant versus adjuvant combined androgen suppression: Radiation Therapy Oncology Group 9413. J Clin Oncol 2003;21:1904-1911. (Pubitemid 46606377)
2. Lawton CA, De Silvio M, Roach M 3rd, et al. An update of the phase III trial comparing whole-pelvic to prostate only radiotherapy and neoadjuvant total androgen suppression: updated analysis of RTOG 94-13. Int J Radiat Oncol Biol Phys 2005;63:S19.
3. Lawton CA, Desilvio M, Roach M 3rd, et al. An update of the phase III trial comparing whole pelvic to prostate only radiotherapy and neoadjuvant to adjuvant total androgen suppression: updated analysis of RTOG 94-13, with emphasis on unexpected hormone/radiation interactions. Int J Radiat Oncol Biol Phys 2007;23:23.
4. Roach M 3rd, DeSilvio M, Valicenti R, et al. Whole-pelvis, "mini-pelvis," or prostate-only external beam radiotherapy after neoadjuvant and concurrent hormonal therapy in patients treated in the Radiation Therapy Oncology Group 9413 trial. Int J Radiat Oncol Biol Phys 2006;66:647-653.
5. Roach M 3rd. Targeted radiotherapy against clinically localized prostate cancer: is pelvic radiotherapy the standard of care for high risk prostate cancer? 3rd International Symposium on Cancer Metastasis and the Lymphovascular System: Basis for Rational Therapy. San Francisco: Abstract Book; 2009:56-57.
6. Pommier P, Chabaud S, Lagrange JL, et al. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. J Clin Oncol 2007;25:5366-5373. (Pubitemid 350232211)
7. Bader P, Burkhard FC, Markwalder R, et al. Is a limited lymph node dissection an adequate staging procedure for prostate cancer? J Urol 2002;168:514-518, discussion 518.
8. Allaf ME, Palapattu GS, Trock BJ, et al. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004;172:1840-1844. (Pubitemid 39363069)
9. Weckermann D, Goppelt M, Dorn R, et al. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostates-pecific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progressionfree survival after radical prostatectomy. BJU Int 2006;97:1173-1178. (Pubitemid 43907316)
10. Weckermann D, Wawroschek F, Harzmann R. Is there a need for pelvic lymph node dissection in low risk prostate cancer patients prior to definitive local therapy? Eur Urol 2005;47:45-50, discussion 50-41.
11. Burkhard FC, Bader P, Schneider E, et al. Reliability of preoperative values to determine the need for lymphadenectomy in patients with prostate cancer and meticulous lymph node dissection. Eur Urol 2002;42:84-90, discussion 90-82.
12. Heidenreich A, Varga Z, Von Knobloch R. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002;167:1681-1686. (Pubitemid 34240702)
13. Briganti A, Chun FK, Salonia A, et al. Critical assessment of ideal nodal yield at pelvic lymphadenectomy to accurately diagnose prostate cancer nodal metastasis in patients undergoing radical retropubic prostatectomy. Urology 2007;69:147-151. (Pubitemid 46161677)
14. Briganti A, Chun FK, Salonia A, et al. Validation of a nomogram predicting the probability of lymph node invasion based on the extent of pelvic lymphadenectomy in patients with clinically localized prostate cancer. BJU Int 2006;98:788-793. (Pubitemid 44368026)
15. Shariat SF, Kattan MW, Erdamar S, et al. Detection of clinically significant, occult prostate cancer metastases in lymph nodes using a splicevariant-specific rt-PCR assay for human glandular kallikrein. J Clin Oncol 2003;21:1223-1231. (Pubitemid 46606397)
16. Pagliarulo V, Hawes D, Brands FH, et al. Detection of occult lymph node metastases in locally advanced node-negative prostate cancer. J Clin Oncol 2006;24:2735-2742. (Pubitemid 46630570)
17. Ferrari AC, Stone NN, Kurek R, et al. Molecular load of pathologically occult metastases in pelvic lymph nodes is an independent prognostic marker of biochemical failure after localized prostate cancer treatment. J Clin Oncol 2006;24:3081-3088. (Pubitemid 46638944)
18. Miyake H, Hara I, Kurahashi T, et al. Quantitative detection of micrometastases in pelvic lymph nodes in patients with clinically localized prostate cancer by real-time reverse transcriptase-PCR. Clin Cancer Res 2007;13:1192-1197. (Pubitemid 46424060)
19. Burkhard FC, Schumacher M, Thalmann GN, et al. Is pelvic lymphadenectomy really necessary in patients with a serum prostate-specific antigen level of <10 ng/ml undergoing radical prostatectomy for prostate cancer? BJU Int 2005;95:275-278.
20. Roach M 3rd, Marquez C, Yuo HS, et al. Predicting the risk of lymph node involvement using the pre-treatment prostate specific antigen and Gleason score in men with clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 1994;28:33-37. (Pubitemid 24012852)
21. Heidenreich A, Bares R, Brenner W, et al. Verfahrensanweisung für die nuklearmedizinische Wächter-Lymphknoten (sentinel lymph node; SLN): d-Diagnostik; 2009. http://www.nuklearmedizin.de/publikationen/leitlinien/ sentinel-lymph-node.php last accessed March 05, 2010.
22. Martinez-Monge R, Fernandes PS, Gupta N, et al. Cross-sectional nodal atlas: a tool for the definition of clinical target volumes in three-dimensional radiation therapy planning. Radiology 1999;211:815-828. (Pubitemid 29249485)
23. Nguyen PL, D'Amico AV. Targeting pelvic lymph nodes in men with intermediate- and high-risk prostate cancer despite two negative randomized trials. J Clin Oncol 2008;26:2055-2056. author reply 2056-2057.
24. Guckenberger M, Baier K, Richter A, et al. Does intensity modulated radiation therapy (IMRT) prevent additional toxicity of treating the pelvic lymph nodes compared to treatment of the prostate only? Radiat Oncol 2008;3:3.
25. Yuen J, Rodrigues G, Trenka K, et al. Comparing two strategies of dynamic intensity modulated radiation therapy (dIMRT) with 3-dimensional conformal radiation therapy (3DCRT) in the hypofractionated treatment of high-risk prostate cancer. Radiat Oncol 2008;3:1.
26. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer: a multicenter validation study. N Engl J Med 1998;339:941-946. (Pubitemid 28455095)
27. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-399.
28. Horenblas S, Jansen L, Meinhardt W, et al. Detection of occult metastasis in squamous cell carcinoma of the penis using a dynamic sentinel node procedure. J Urol 2000;163:100-104.
29. Holl G, Dorn R, Wengenmair H, et al. Validation of sentinel lymph node dissection in prostate cancer: experience in more than 2,000 patients. Eur J Nucl Med Mol Imaging 2009;36:1377-1382.
30. Weckermann D, Dorn R, Holl G, et al. Limitations of radioguided surgery in high-risk prostate cancer. Eur Urol 2007;51:1549-1556, discussion 1556-1548.
31. Wawroschek F, Vogt H, Wengenmair H, et al. Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer: technique and results of the first 350 cases. Urol Int 2003;70:303-310. (Pubitemid 36566262)
32. Wawroschek F, Vogt H, Weckermann D, et al. Radioisotope guided pelvic lymph node dissection for prostate cancer. J Urol 2001;166:1715-1719. (Pubitemid 32953393)
33. Wawroschek F, Wagner T, Hamm M, et al. The influence of serial sections, immunohistochemistry, and extension of pelvic lymph node dissection on the lymph node status in clinically localized prostate cancer. Eur Urol 2003;43:132-136, discussion 137.
34. Wawroschek F, Wengenmair H, Senekowitsch-Schmidtke R, et al. Prostate lymphoscintigraphy for sentinel lymph node identification in canines: reproducibility, uptake, and biokinetics depending on different injection strategies. Urol Res 2003;31:152-158. (Pubitemid 36962021)
35. Weckermann D, Holl G, Dorn R, et al. Reliability of preoperative diagnostics and location of lymph node metastases in presumed unilateral prostate cancer. BJU Int 2007;99:1036-1040. (Pubitemid 46587919)
36. Ganswindt U, Paulsen F, Corvin S, et al. Intensity modulated radiotherapy for high risk prostate cancer based on sentinel node SPECT imaging for target volume definition. BMC Cancer 2005;5:91.
37. Ganswindt U, Paulsen F, Corvin S, et al. Optimized coverage of high-risk adjuvant lymph node areas in prostate cancer using a sentinel node-based, intensity-modulated radiation therapy technique. Int J Radiat Oncol Biol Phys 2007;67:347-355. (Pubitemid 46108338)
38. Lawton CA, Michalski J, El-Naqa I, et al. RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 2009;74:383-387.
39. Vermeeren L, Valdes Olmos RA, Meinhardt W, et al. Value of SPECT/CT for detection and anatomic localization of sentinel lymph nodes before laparoscopic sentinel node lymphadenectomy in prostate carcinoma. J Nucl Med 2009;50:865-870.
40. Krengli M, Ballare A, Cannillo B, et al. Potential advantage of studying the lymphatic drainage by sentinel node technique and SPECT-CT image fusion for pelvic irradiation of prostate cancer. Int J Radiat Oncol Biol Phys 2006;66:1100-1104. (Pubitemid 44633524)
41. Kizu H, Takayama T, Fukuda M, et al. Fusion of SPECT and multidetector CT images for accurate localization of pelvic sentinel lymph nodes in prostate cancer patients. J Nucl Med Technol 2005;33:78-82. (Pubitemid 44783742)
42. Hacker A, Jeschke S, Leeb K, et al. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection. J Urol 2006;176:2014-2018, discussion 2018-2019.
43. Sharma N, Neumann D, Macklis R. The impact of functional imaging on radiation medicine. Radiat Oncol 2008;3:25.
44. Fukuda M, Egawa M, Imao T, et al. Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer. J Urol 2007;177:1313-1317, discussion 1317.
45. Bastide C, Brenot-Rossi I, Garcia S, et al. Radioisotope guided sentinel lymph node dissection in patients with localized prostate cancer: results of the first 100 cases. Eur J Surg Oncol 2009;35:751-756.
46. Jeschke S, Beri A, Grüll M, et al. Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer. Eur Urol 2008;53:126-132.